Compound sulfamethoxazole granules
Indication
1. Urinary tract infection caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morganella; 2. Acute otitis media in children over 2 years old caused by Streptococcus pneumoniae or Haemophilus influenzae; 3. Acute exacerbation of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae; 4. Intestinal infection and Shigella infection caused by sensitive strains of Shigella flexneri or Shigella sonnei; 5. This product is the first choice for the treatment of Pneumocystis carinii pneumonia; 6. For the prevention of Pneumocystis carinii pneumonia, it can be used in patients with a history of at least one attack of Pneumocystis carinii or in adults infected with HIV
Precautions
1. This product is contraindicated for infants under 2 months old; 2. This product is contraindicated for those who are allergic to SMZ and TMP; 3. This product is contraindicated for patients with megaloblastic anemia because it blocks the metabolism of folic acid and aggravates the folate deficiency in patients with this disease; 4. This product is contraindicated for patients with severe liver and kidney damage; 5. Pregnant women should avoid using this product; 6. This product should not be used by breastfeeding women.
Special Population Medication
Precautions for children: This product is contraindicated for infants under 2 months old. Precautions for pregnancy and lactation: This product is contraindicated for pregnant and lactating women.
Packaging Specification
Sulfadimethoxazole 0.8 g, trimethoprim 0.16 g
Manufacturer
Dajiaweikang Biopharmaceutical Co., Ltd.
-
Founded in:
2022-06-15 -
Address:
No. 9, Hantai Road, Hunan Hanshou High-tech Industrial Park -
Tax NO.:
91430722MABNWDNW6X -
Registered Funds:
213.15 million yuan -
Email: